UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders

Neuroscience and biobehavioral reviews, 2022-01, Vol.132, p.1114-1136

2022

Link zum Volltext

Verfügbarkeit prüfen

Serotonin receptors in depression and anxiety: Insights from animal studies

Life Sciences, 2018-10, Vol.210, p.106-124

2018

Link zum Volltext

Verfügbarkeit prüfen

The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4307

2021

Link zum Volltext

Verfügbarkeit prüfen

The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress

Psychopharmacology, 2021-08, Vol.238 (8), p.2249-2260

2021

Link zum Volltext

Verfügbarkeit prüfen

The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α1-Adrenolytic Properties

International journal of molecular sciences, 2022-09, Vol.23 (18), p.10381

2022

Link zum Volltext

Verfügbarkeit prüfen

Novel Arylpiperazine Derivatives of Salicylamide with α1-Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats

International journal of molecular sciences, 2022-12, Vol.24 (1), p.293

2022

Link zum Volltext

Verfügbarkeit prüfen

Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents

International journal of molecular sciences, 2022-12, Vol.23 (24), p.15929

2022

Link zum Volltext

Verfügbarkeit prüfen

The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia

Pharmaceuticals (Basel, Switzerland), 2021-10, Vol.14 (11), p.1065

2021

Link zum Volltext

Verfügbarkeit prüfen

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models

PloS one, 2015-11, Vol.10 (11), p.e0142499-e0142499

2015

Link zum Volltext

Verfügbarkeit prüfen

Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice

Pharmaceuticals (Basel, Switzerland), 2023-03, Vol.16 (3), p.399

2023

Link zum Volltext

Verfügbarkeit prüfen

Protease-activated receptor 2 activation induces behavioural changes associated with depression-like behaviour through microglial-independent modulation of inflammatory cytokines

Psychopharmacology, 2022-01, Vol.239 (1), p.229-242

2022

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity

PloS one, 2015-10, Vol.10 (10), p.e0141327-e0141327

2015

Link zum Volltext

Verfügbarkeit prüfen

Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice

Pharmaceuticals (Basel, Switzerland), 2023-01, Vol.16 (2), p.175

2023

Link zum Volltext

Verfügbarkeit prüfen

HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats

PloS one, 2016-10, Vol.11 (10), p.e0165495-e0165495

2016

Link zum Volltext

Verfügbarkeit prüfen

The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signalling

Journal of psychopharmacology (Oxford), 2020-12, Vol.34 (12), p.1431-1442

2020

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT1A and D2 Receptors

Pharmaceuticals (Basel, Switzerland), 2021-07, Vol.14 (8), p.744

2021

Link zum Volltext

Verfügbarkeit prüfen

Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?

Pharmacology & therapeutics (Oxford), 2021-11, Vol.227, p.107872-107872, Article 107872

2021

Link zum Volltext

Verfügbarkeit prüfen

HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling

Frontiers in pharmacology, 2018-10, Vol.9, p.1146-1146

2018

Link zum Volltext

Verfügbarkeit prüfen

MK-801 and cognitive functions: Investigating the behavioral effects of a non-competitive NMDA receptor antagonist

Psychopharmacology, 2023-12, Vol.240 (12), p.2435-2457

2023

Link zum Volltext

Verfügbarkeit prüfen

Beyond dopamine: Novel strategies for schizophrenia treatment

Medicinal research reviews, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats

Frontiers in pharmacology, 2016-08, Vol.7, p.229-229

2016

Link zum Volltext

Verfügbarkeit prüfen

Sex-dependent differences in animal cognition

Neuroscience and biobehavioral reviews, 2023-10, Vol.153, p.105374-105374, Article 105374

2023

Link zum Volltext

Verfügbarkeit prüfen

Biased agonism in drug discovery: Is there a future for biased 5-HT 1A receptor agonists in the treatment of neuropsychiatric diseases?

Pharmacology & therapeutics (Oxford), 2021-11, Vol.227, p.107872

2021

Link zum Volltext

Verfügbarkeit prüfen

Potential antidepressant and anxiolytic properties of new phenylpiperazine derivaties

Pharmacological reports, 2012-03, Vol.64 (2), p.503-503

2012

Link zum Volltext

Verfügbarkeit prüfen

The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect

Pharmacological reports, 2016-04, Vol.68 (2), p.263-274

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(96)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(51)
Animals
(41)
Pharmacology & Pharmacy
(39)
Mice
(23)
Humans
(20)
Neurosciences
(20)
Male
(19)
Neurosciences & Neurology
(19)
Chemistry, Medicinal
(18)
Pharmacy
(17)
5-Ht
(16)
Antidepressive Agents - Pharmacology
(14)
Drug Safety And Pharmacovigilance
(14)
Pharmacotherapy
(14)
Rats
(14)
Piperazines - Pharmacology
(13)
Antidepressants
(11)
Depression
(11)
Anxiety
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders

Serotonin receptors in depression and anxiety: Insights from animal studies

The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders

The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress

The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α1-Adrenolytic Properties

Novel Arylpiperazine Derivatives of Salicylamide with α1-Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats

Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents

The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models

Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice

Protease-activated receptor 2 activation induces behavioural changes associated with depression-like behaviour through microglial-independent modulation of inflammatory cytokines

A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity

Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice

HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats

The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signalling

Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT1A and D2 Receptors

Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?

HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling

MK-801 and cognitive functions: Investigating the behavioral effects of a non-competitive NMDA receptor antagonist

Beyond dopamine: Novel strategies for schizophrenia treatment

Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats

Sex-dependent differences in animal cognition

Biased agonism in drug discovery: Is there a future for biased 5-HT 1A receptor agonists in the treatment of neuropsychiatric diseases?

Potential antidepressant and anxiolytic properties of new phenylpiperazine derivaties

The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect

Suchergebnisse filtern